Novonesis A/S (OTC:NVZMY) Shares Up 6.4% – Still a Buy?

Novonesis A/S (OTC:NVZMYGet Free Report)’s stock price rose 6.4% during trading on Thursday . The stock traded as high as $60.82 and last traded at $59.31. Approximately 96,785 shares traded hands during trading, an increase of 201% from the average daily volume of 32,134 shares. The stock had previously closed at $55.73.

Novonesis A/S Stock Up 4.1 %

The stock has a market cap of $28.93 billion, a PE ratio of 39.09, a PEG ratio of 2.79 and a beta of 0.91. The company has a 50-day moving average of $58.38.

About Novonesis A/S

(Get Free Report)

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Recommended Stories

Receive News & Ratings for Novonesis A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novonesis A/S and related companies with MarketBeat.com's FREE daily email newsletter.